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Chimeric virus-like particles (cVLPs) are protein-based nanostructures applied as
investigational vaccines against infectious diseases, cancer, and immunological
disorders. Low solubility of cVLP vaccine candidates is a challenge that can prevent
development of these very substances. Solubility of cVLPs is typically assessed
empirically, leading to high time and material requirements. Prediction of cVLP solubility
in silico can aid in reducing this effort. Protein aggregation by hydrophobic interaction
is an important factor driving protein insolubility. In this article, a recently developed
soft ensemble vote classifier (sEVC) for the prediction of cVLP solubility was used
based on 91 literature amino acid hydrophobicity scales. Optimization algorithms were
developed to boost model performance, and the model was redesigned as a regression
tool for ammonium sulfate concentration required for cVLP precipitation. The present
dataset consists of 568 cVLPs, created by insertion of 71 different peptide sequences
using eight different insertion strategies. Two optimization algorithms were developed
that (I) modified the sEVC with regard to systematic misclassification based on the
different insertion strategies, and (II) modified the amino acid hydrophobicity scale tables
to improve classification. The second algorithm was additionally used to synthesize
scales from random vectors. Compared to the unmodified model, Matthew’s Correlation
Coefficient (MCC), and accuracy of the test set predictions could be elevated from
0.63 and 0.81 to 0.77 and 0.88, respectively, for the best models. This improved
performance compared to literature scales was suggested to be due to a decreased
correlation between synthesized scales. In these, tryptophan was identified as the most
hydrophobic amino acid, i.e., the amino acid most problematic for cVLP solubility,
supported by previous literature findings. As a case study, the sEVC was redesigned
as a regression tool and applied to determine ammonium sulfate concentrations for the
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precipitation of cVLPs. This was evaluated with a small dataset of ten cVLPs resulting in
an R2 of 0.69. In summary, we propose optimization algorithms that improve sEVC
model performance for the prediction of cVLP solubility, allow for the synthesis of
amino acid scale tables, and further evaluate the sEVC as regression tool to predict
cVLP-precipitating ammonium sulfate concentrations.
Keywords: virus-like particles, solubility, hydrophobicity scales, machine learning, precipitation, optimization
INTRODUCTION
Protein solubility is a generally recognized problem in
biopharmaceutical drug development. The fact that poor
solubility can hamper a molecule’s development is a well-
known challenge in chimeric virus-like particle (VLP) process
development. VLPs are multimeric structures based on viral
proteins, which are employed as vaccines, or delivery vehicles
for proteins or nucleic acids (McAleer et al., 1984; Muratori
et al., 2010; Kaczmarczyk et al., 2011; Strods et al., 2015; Bryan
et al., 2016). For example, VLPs are applied as vaccines against
hepatitis B virus or human papillomavirus (McAleer et al., 1984;
Bryan et al., 2016). Chimeric VLPs (cVLPs) are VLPs decorated
with foreign epitopes altering the function of the unmodified
VLPs by, for example, directing the patient’s immune response
toward the inserted epitope (Yoshikawa et al., 1993; Klamp et al.,
2011). While this flexibility of antigenic display is one of the
major advantages of VLPs (Pumpens et al., 2008), recombinant
insertion of epitopes often results in expression of insoluble
structures (Karpenko et al., 2000; Billaud et al., 2005). Factors
affecting cVLP solubility have been described as, for example,
insert charge (Whitacre et al., 2009), amino acid side chain
volume (Karpenko et al., 2000), or the content of specific amino
acids, such as tryptophan or arginine (Vormittag et al., 2020).
None of these individual attributes describe the cVLP solubility
landscape comprehensively. This is underlined by findings, in
which combining different attributes improved the solubility
model’s performance (Vormittag et al., 2020). Each amino acid
makes a unique contribution to protein solubility, e.g., based
on its charge, volume, or specific interactions. In recent years,
a great number of so-called hydrophobicity scales have been
derived that aim to serve in an (almost) calibration-free model
to describe hydrophobicity-related problems based on amino
acid-specific hydrophobicity values.
Already in 1962, Tanford pointed out that hydrophobic
interaction is a key factor influencing the stability of globular
protein conformation (Tanford, 1962). Nozaki and Tanford
(1971) measured transfer free energies of amino acid side chains
into ethanol and dioxane, deriving an early hydrophobicity scale.
They describe the hydrophobicity scale value of an amino acid
as, for example, its tendency to be located in the interior of a
protein. This idea of a scale to describe an amino acid’s tendency
to partition into exterior or interior regions of a protein is an
Abbreviations: cVLP, chimeric virus-like particle; FN, false negative; FP, false
positive; HBcAg, hepatitis B virus core antigen; MAD, median absolute deviation;
MCC, Matthew’s correlation coefficient; MC-CV, Monte Carlo cross-validation;
PC, principal component; PCA, principal component analysis; sEVC, soft
ensemble vote classifier; TF, true false; TP, true positive; VLP, virus-like particle.
assumption that does not take into account 3-D-specific effects.
If 3-D-specific effects were negligible, a linear or non-linear
function should exist that perfectly describes a protein’s solubility
based on its amino acid composition. The fact that this is
probably not the case has been extensively shown, directly or
indirectly, for example, by several studies on protein solubility
prediction yielding only about 60–80% accuracy (Idicula-Thomas
et al., 2006; Smialowski et al., 2006; Magnan et al., 2009;
Hebditch et al., 2017), or detailed mechanistic studies on
protein structure and assembly. The latter is illustrated by the
complex behavior of VLPs. Tyrosine can be regarded as a
hydrophobic (aromatic ring) or polar (hydroxyl group) amino
acid. Interestingly, it is required for Hepatitis B core antigen
(HBcAg) to form capsids, buried in a hydrophobic pocket
(Wynne et al., 1999). A mutational form, replacing tyrosine 132
by alanine, prohibits particle assembly (Bourne et al., 2009).
The predominant quaternary structure of this HBcAg mutant is
therefore a dimer instead of the 180- or 240-meric capsid. This
comes with great changes in physicochemical and biophysical
behavior as the mass of a solvatized entity differs by 90- to
120-fold. Obviously, this behavior cannot be explained by one
universal hydrophobicity scale, as this is an effect with a strong
3-D spatial component.
In a recent article by our group, we applied a soft ensemble
vote classifier (sEVC) with embedded feature selection to predict
cVLP solubility, based on 91 hydrophobicity scales (Vormittag
et al., 2020) to harness the information contained in multiple
scales. This can help overcome the limitations of a sequence-
based approach by expanding the dimensionality of the sequence-
based descriptions by using different scales in one model.
In said study, a feature selection algorithm selected the best
features to be included in the model based on a training set.
Individual hydrophobicity scale performance for classification
ranged from 54 to 85%, which underpins that hydrophobicity
scales cannot be universal. The choice of hydrophobicity scales by
the algorithm and the analysis of the best- and worst-performing
scales revealed dominant roles for arginine and tryptophan in
cVLP solubility. In another study on the prediction of peptide
aggregation propensity, feature selection has been successfully
employed to select the best of 560 features, showing some
overlap with regard to best features with our previous study
(Fang et al., 2013). Both these publications combine theoretical
physicochemical data with statistical methods to predict a
biophysical property by selecting appropriate physicochemical
measures. Compared to pure statistical regression, these
models therefore contain physicochemical information, which
is advantageous for calibration on smaller datasets and for
interpretation of the data.
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Zviling et al. (2005) came to similar conclusions in their
work on the prediction of transmembrane helical regions.
Based on two existing amino acid scales, provided by Kyte
and Doolittle and Goldman, Engelmann and Steitz (Kyte and
Doolittle, 1982; Engelman et al., 1986), they generated a set
of new hydrophobicity scales by optimization using a genetic
algorithm on a cross-validation set. Both Zviling’s and our
approach combine real experimental physicochemical data,
contained in hydrophobicity scales, with a statistical adjustment
to the problem to be modeled. This ensures that prediction is
based on actual physicochemical groundwork. The degree of
statistical adjustment, however, is larger, when a 20-dimensional
function is optimized, such as by optimization of scale tables
in Zviling’s work, than with calibration of decision trees
that only shift classification borders in the one-dimensional
target function space.
The present article describes approaches to optimize and
tweak our recently developed model to improve prediction
accuracy, learn more about the data, and to extend the model
to other biophysical parameters. An optimization procedure
for the synthesis of amino acid scale tables is one approach
to improve model performance. To ensure that overfitting is
avoided, this approach would benefit from a large balanced
dataset, as was used in our recent study. These synthesized
scales would be tailored to the problem they are optimized
on and therefore have the potential to improve model
performance and reveal dominant roles of amino acids for
classification of the dataset.
In our previous study, we demonstrated the potential of
optimizing the model’s prediction based on the contingency
matrices of the individual insertion strategies (Vormittag et al.,
2020). The dataset used consisted of 568 chimeric HBcAg
constructs, created by a grid of 71 different inserts and eight
insertion strategies. The eight different insertion strategies in
this study define where in the major immunodominant region
of the HBcAg molecule the epitope is inserted and which
amino acids are deleted. The different strategies are meant
to optimize the integration of the foreign epitope into the
VLP sequence and would ideally result in an integration that
produces a soluble cVLP. Analyzing the strategies showed that the
model systematically overestimated or underestimated certain
insertion strategies with respect to the predicted solubility
(Vormittag et al., 2020). To recapitulate briefly, a strategy
that is overrepresented in the training false-positive (FP)
group has overestimated solubility in relation to the other
strategies. This means that this strategy is particularly bad
for solubility in the perspective of the training dataset. The
model is, at this stage, incapable of describing this different
behavior. As previously suggested, this could be related to 3-
D phenomena that cannot be described by a sequence-based
approach (Vormittag et al., 2020). Knowledge of the above-
described systematic misclassification helps (a) to conclude that
this insertion strategy may be disadvantageous with respect to
solubility, and (b) to adjust the model, so that the model’s
blind spot is compensated. The latter can be achieved by
modifying the model predictions specifically for those insertion
strategies, for which systematic misclassification can be observed
in the training set.
The introduction of a foreign epitope to be displayed on the
VLP surface has implications on many facets of the product
and the process. The main question addressed by our work –
the solubility of cVLP candidates after cell lysis – is typically a
decision point where candidates drop out of the candidate pool.
In this large dataset, this leaves half of the candidates to choose
from Vormittag et al. (2020). This number will be cut down
to very few candidates throughout the development process.
Besides solubility, several other biophysical, or physicochemical
parameters are determinants in the development process of a
cVLP candidate. The most important property is the candidates’
ability to induce an immune response against the target structure,
the basis for its efficacy (Klamp et al., 2011; Roseman et al.,
2012; Frietze et al., 2016). Therefore, the introduced foreign
epitope has to be properly displayed and accessible on the
molecular surface, which is something that can very probably
not be described by amino acid scale-based models and requires
detailed 3-D structural studies (Roseman et al., 2012). Another
process-related property that can vary among the candidates is
their structural and phase behavior as a function of the solution
environment. VLPs are complex nanostructures which are held
together by intra- and intermolecular forces, such as electrostatic
and hydrophobic interactions and disulfide bonds. Their complex
structural behavior is dependent on the introduced foreign
epitope. In a previous work by our group, we investigated the re-
assembly of disassembled HBcAg cVLPs (in the form of HBcAg
dimers) by increasing ionic strength by diafiltration (Rüdt et al.,
2019). We observed that the diafiltration volumes – an indicator
of progress in buffer exchange and therefore ionic strength –
that were required to complete the VLP assembly reaction
varied between the three constructs. Based on zeta potential
measurements, this behavior could be related to surface charge.
In another study, a high-throughput 3-D structure generation
workflow was developed that we applied on exactly these three
constructs in their disassembled form to calculate a surface charge
that correlated well with the zeta potential measurements (Klijn
et al., 2019). This is a good example of in silico representations
of physicochemical properties, which pave the way for model-
assisted rather than empirical process development. This said,
it seemed promising to test the sEVC model to predict other
process-related properties. One such property is the required
concentration of ammonium sulfate to precipitate cVLPs, a
typical process step in cVLP downstream processing (Hillebrandt
et al., 2020). Precipitation of cVLPs can typically be achieved
with an ammonium sulfate concentration that leaves most of
the contaminants in solution (Kazaks et al., 2017). Once the
supernatant containing these contaminants is discarded, the
cVLPs can be resolubilized, resulting in high yields with the
potential of increasing product concentration. The ammonium
sulfate concentration required for cVLP precipitation is typically
determined in screening experiments (Hillebrandt et al., 2020).
To reduce required time and resources, regression for the
estimation of the ammonium sulfate concentration for different
cVLPs would therefore be highly interesting.
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We have recently shown that ensembles of individual
classifiers based on hydrophobicity scales and amino acid
sequences are potent classifiers for cVLP solubility. The objective
of this study is to evaluate the potential of different optimization
strategies to improve our recently developed sEVC framework
and to apply the sEVC to another biophysical parameter. We
therefore combined the sEVC with optimization algorithms to
improve generated models and to learn more about the data
obtained. Optimization algorithms employed in this study aimed
to (I) reduce systematic misclassification based on insertion
strategies, (II) optimize and generate amino acid scale tables, and
(III) combine both optimization strategies to maximize model
performance. Finally, we show some perspective on how to apply
the model to another biophysical parameter, i.e., ammonium
sulfate concentration for cVLP precipitation, by transforming the
model to a regression tool.
MATERIALS AND METHODS
Dataset
For an overview of the methodology applied to this work,
we recommend reading our previous article on the sEVC for
chimeric VLP solubility prediction (Vormittag et al., 2020).
The dataset is equivalent to that used in said previous study,
comprising amino acid sequence and binary solubility data
of chimeric HBcAg constructs. Chimeric HBcAg was based
on C-terminally truncated, His-tagged Hepatitis B virus core
protein, modified with 71 different inserts and eight unique
insertion strategies. An insertion strategy describes where in the
major immunodominant region of HBcAg the foreign epitope
is inserted and how many amino acids of the native protein are
deleted. All possible combinations of the 71 inserts and eight
strategies result in 568 constructs/observations. The literature
hydrophobicity scales used in this study can be found in
our recent work and the Supplementary Table S1, originally
derived from AAindex (Kawashima et al., 2007), the SPLIT
4.0 server (Juretić et al., 1993), and ProtScale (Gasteiger et al.,
2005), and put together by Simm et al. (2016). Reversed scales
were treated as duplicates, and therefore removed if a non-
reversed scale was available, resulting in 91 hydrophobicity
scales. For all models, a training set of 384 observations was
used, which was created once by stratified sampling based on
the identity of the inserts and insertion strategies (Vormittag
et al., 2020). The remaining 184 observations were used as an
external test set. For Monte Carlo cross-validation (MC-CV),
a 1:1 random split of the training set was applied to each
validation run.
Soft Ensemble Vote Classifier
The sEVC applied in this study is described in detail in the
above-mentioned recent study by our group and was only slightly
modified. Briefly, the sEVC aggregates the solubility predictions
of individual classifiers, which classify based on hydrophobicity
features calculated by hydrophobicity scales and sequence data.
The features Fp are derived by accumulating hydrophobicity
values of amino acids Hyd(aa), as prescribed by a hydrophobicity
scale, for the entire amino acid sequence [aa1, aa2, . . . , aan] of





Classifiers are one-level decision trees induced from these
hydrophobicity features, trained using Gini’s diversity index as
impurity measure (Gini, 1912; Windeatt and Ardeshir, 2004).
The classifiers return a class (“soluble”/+1 or “insoluble”/-1) with
a probability associated with the respective child node in the
decision tree. The classifier’s vote v is the probability with the sign
associated with the respective class and therefore falls between
−1 and +1. Aggregation of all votes vi results in the continuous
prediction value p of the sEVC, which is normalized by the
number of included scales n, again falling between −1 and +1,






This continuous prediction value is subsequently discretized,
where for p > 0, the prediction is “soluble” or +1 and for p ≤
0, it is “insoluble” or −1. In the sEVC, an embedded feature
selection algorithm informs about the potency of the individual
classifiers to predict solubility and sorts them according to
their feature importance, namely their Matthew’s correlation
coefficient (MCC) on prediction of the training data as defined
in Eq. (3).
MCC =
TP × TN − FP × FN
√
(TP + FP)(TP + FN)(TN + FP)(TN + FN)
(3)
TP, TN, FP, and FN are true-positive, true-negative, false-
positive, and false-negative classifications (contingency matrix
of training, validation, and test set). In our previous study,
feature selection was based on accuracy, which is, however, biased
when unbalanced datasets are considered (Powers, 2011). For
model validation, an MC-CV procedure with embedded feature
selection is run to inform about the optimal number of included
classifiers. The sEVC could theoretically be composed of any
combination of available classifiers, where each combination is an
individual model. In this study, the n best classifiers, according
to feature selection, are included, where n ranges from 1 to
the maximum number of available classifiers. For the dataset
of literature scales, n is 91. In the scale generation procedure
described below, n ranges from 1 to 16.
The training/validation set is selected randomly from the full
training set in each MC-CV run. The sEVC including 1 to n
classifiers, sorted by descending feature importance, is probed on
these MC-CV datasets. In the original study on the sEVC, model
validation datasets were newly constructed for each of the 91
models, while in this study, the same MC-CV dataset within one
MC-CV run is used for all n models. This is reasonable as each of
the models is evaluated on the same dataset within one MC-CV
run, thus increasing comparability while reducing computational
resources. The validation procedure informs about the model
performance dependent on the number of included classifiers.
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FIGURE 1 | Workflow of optimization procedures. (A) The insertion strategy optimization is based on modifying the classifier for a specific strategy to increase model
performance. In a 25-fold Monte Carlo cross-validation (MC-CV), the previous modifier is evaluated and a new modifier is derived, based on systematic
misclassification in the false-positive and negative group, specific for certain insertion strategies. This results in the current modifier mcurrent and current MCCcurrent. If
MCCcurrent is better than previous best MCC, the best MCC and modifier are updated and used for the next iteration. If the MCCcurrent is lower than the best MCC
within a defined acceptance margin of 0.05, the current modifier is used for the next iteration. If it is below this acceptance margin, the MCC and modifier are reset to
the previous best MCC and modifier. If for 50 times, no improvement on the MCC has been made, the iteration is stopped. (B) Scale optimization and synthesis are
based on an optimization of the individual amino acid’s hydrophobicity values in the hydrophobicity scale. In each iteration the previous scale is modified and probed
in 25-fold MC-CV, resulting in a current MCC and scale s. The iteration rules are comparable to the insertion strategy optimization, with the difference that the
acceptance margin is higher with 0.2 and the modified scales, as opposed to the modifiers in the insertion strategy optimization, are stored and updated.
This information can be used for generation of the final model
based on all training data to predict the external test set.
Optimization Based on Insertion
Strategies
An optimization algorithm focusing on the insertion strategies
was developed, based on a loop of model generation, evaluation,
and modification (Figure 1A). The dataset used for this
optimization procedure is the training set of 384 observations and
all 91 literature hydrophobicity scales (Supplementary Table S1).
In the first iteration, a 25-fold MC-CV is computed and an
accumulated validation set contingency matrix is calculated.
This matrix contains information on the accumulated number
of validation TP, TN, FP, and FN classifications dependent on
the insertion strategy for all 25 MC-CV runs. The largest
absolute value of FN − FP classifications defines which strategy’s
prediction is modified in this iteration and what the sign of
this modification is. If FN > FP, it is positive, if FN < FP, it is
negative. A strategy that has more FN than FP should be classified
more positively by the classifier, in order to push FN observations
into the TP group. This is realized by modifying the accumulated
continuous prediction values [compare also Eq. (2)] of the
sEVC. A modification vector m contains the information on
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how this aggregated prediction value is modified individually for
each strategy, imaginable as shifting the classification boundary
(Figure 1A; while, in fact, the predictions are shifted instead
of the classification boundary). In each iteration, the vector is
changed by an absolute 0.01 for the strategy and sign identified as
described above. The first iteration is calculated on an unmodified
model, providing the modification vector for the second iteration.
In each iteration, the sEVC modified by the previous
modification vector is evaluated in the 25-fold MC-CV, resulting
in a new median validation MCC value, i.e., target function to
be maximized. This value is the median of all models’ median
validation MCC. Therefore, the target function takes into account
the entire model space of 1 to 91 included classifiers. If this
is in an acceptable range (equal to or at maximum 0.05 worse
than the best previous median MCC), then the accumulated
contingency matrix of this iteration is used to calculate a new
modification vector for the next iteration. The acceptable range
was determined in pre-experiments, so that early termination of
the algorithm was avoided while limiting model deterioration. If
the MCC is better than the best MCC so far, the modification
vector is stored as best modification vector, and future iterations
are compared to this MCC. If the MCC is worse and outside the
acceptable range, the modification vector is reset to the current
best modification vector. If for 50 times, no improvement on
the MCC has been made, the optimization is stopped. For the
evaluation of optimized model performance, the model with
the best MCC during optimization is chosen and the respective
modification vector is applied within the sEVC in order to
predict in 1000-fold MC-CV and to predict the external test
set. For each of the 91 models, the validation procedure results
in a median validation MCC and accuracy. For evaluation, the
median of these values (“overall median”) is compared for the
MCC and accuracy, respectively. The metric to compare initial
and optimized model performance is the change of these values
in percent, where the difference between optimized and initial
performance values is divided by their maximum range, i.e., 1 and
2 for accuracy and MCC, respectively.
Synthesis of Amino Acid Scales
A second algorithm was created to modify amino acid scales to
(I) synthesize new amino acid scales and (II) optimize existing
scales specifically for the presented VLP solubility problem
(Figure 1B). The two algorithms are almost identical and are, in
the following, explained by the example of scale synthesis. Each
scale is optimized from an initial scale that contains normally
distributed pseudorandom numbers for each of the 20 encoded
amino acids. In each iteration, the scale s of the preceding run is
adjusted with a modifier m Eqs (8, 9). The modifier is designed
to move the average FP and FP feature value in the direction of
the classification boundary, which is the cut point of the one-level
decision tree, thus aiming to decrease false classification. This is
done independent of insertion strategies. The modifier’s direction
is determined by average feature values of the classification
groups FN and FP and the difference in frequency of individual
amino acids. The average feature values FFN and FFP and mean
amino acid frequency vectors aFN and aFP are derived from a
25-fold MC-CV run with the scale s of the previous iteration.
Herein, the amino acid frequency vectors describe the frequency
of the individual amino acids within the groups of FN and FP
classification, respectively. The average feature values fFN, fFP,
and their differences are
fFN = a′FNs, (4)
fFP = a′FPs, (5)
and
1f = fFN − fFP. (6)
The vector of the difference in amino acid frequency is given by
1aFN,FP = (aFN − aFP) (7)
The modifier used in this optimization loop is vector
m = 1f 1aFN,FP, (8)
which is used in a centered and unit variance-scaled form m̄. In
each iteration, a scale is modified as prescribed in Eq. (9).
si+1 = si + rm̄, (9)
where si and si+1 are the previous and the modified scale,
respectively, and r is the modification rate, which was 1% for scale
synthesis. After modification, the new scale is also centered and
scaled to unit variance. Therefore, the extent of modification is
comparable in all iterations, as it corresponds to an average of 1%
of unit variance.
The modified scale is probed in a 100-fold MC-CV run
resulting in a median MCC value. This current MCC value is
compared to the best previous MCC value. If it is better, it is
stored as the new best MCC value with associated new best scale.
If it is worse, the new scale is still accepted, as long as the MCC
does not fall below an acceptance margin, which is 0.2, where
the scale and MCC are reset to the previous best iteration. The
acceptance margin is larger than in the insertion strategy-based
optimization, as model performance fluctuated more with this
second optimization strategy. If no new best scale is created for
50 times consecutively, the optimization is stopped and the best
scale and MCC are returned. For the generation of scales, either
the full training set or subsets thereof were used. When the full
training set is used, one scale is generated by the algorithm. When
two (equally sized) subsets are used, two scales are generated
by the algorithm. The algorithm was run with up to 16 subsets,
which in turn resulted in 16 different scales. Subsets were either
created by random split into evenly sized subsets or split by
insertion strategies.
Additionally, this algorithm was used to optimize literature
scales. Based on the full training set with 384 observations, the
91 literature scales were used as scales in an initial iteration,
where the optimization was performed for each scale individually
at a rate of 5%. Other parameters were identical to the scale
generation procedure.
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Analysis of Performance Data for
Optimizations
Evaluation of optimized and non-optimized models was always
based on 1000-fold MC-CV, returning median MCC and median
absolute deviation (MAD) of MCC. The external test set consisted
of 184 observations, remaining after stratified sampling of 384
training observations from the full dataset. For all models, the
same external test set was used.
Redesigning the Model for Regression of
Precipitation Data
Ten cVLP constructs of strategy H were experimentally evaluated
for cVLP-precipitating ammonium sulfate concentration. The
ammonium sulfate concentration screening procedure was
performed as described in a recent article on precipitation
of HBcAg VLPs (Hillebrandt et al., 2020). Briefly, clarified
Escherichia coli lysate, containing HBcAg VLPs, was adjusted to
0.25% polysorbate 20 and then precipitated with 4 M ammonium
sulfate stock solution to different target concentrations. The
ammonium sulfate concentration required to precipitate most of
the cVLPs was determined visually based on SDS PAGE scans.
Scales generated by the above-described algorithm, that is,
those derived from randomly splitting the training set into eight
equal parts, were used to train a model based on all observations
with insertion strategy H. Evaluation of the model was performed
on the prediction of the 1000-fold MC-CV set for eight models
composed of 1–8 classifiers. As opposed to the classification
for solubility, the continuous prediction value of the models
[compare also Eq. (2)] was not discretized. The mean resulting
prediction value of the MC-CV runs was subsequently used to
be correlated with the experimental data in linear regression. The
order of the scales was derived from feature selection. The data
were fit using MATLAB’s fitlm function and evaluated by the
ordinary R2.
RESULTS AND DISCUSSION
Optimization Based on Insertion
Strategies
An optimization procedure was developed, which, based on 25-
fold MC-CV, adjusts the model’s predictions for the insertion
strategies individually based on a modification vector. This
modification vector is applied before discretizing the continuous
scale of the aggregated sEVC votes by increasing (higher
solubility) or decreasing (lower solubility) the continuous
prediction value.
The optimized model, obtained after 130 iterations, showed
an increase in median validation MCC values from 0.63 to 0.69
(Table 1). Most notable modifications are made on predictions
of insertion strategies E and H, resulting in a strategy-specific
accuracy increase of 12% for both strategies, while the MCC
increased by 8% for strategy E and decreased by 1% for strategy H.
This is also illustrated by the number decrease of these strategies
in the respective false classification groups (Figure 2). Overall,
there is a similar true-positive (TP), and false-negative (FN)
number, indicated by the mean over insertion strategies (red
line), while true negative (TN) is increased and false positive
(FP) decreased. The constant numbers in FN are explained by
the increase in the number of strategy H in this group, balancing
out the decrease of strategy E in FN. Making strategy H more
negative pushed FP-classified observations to TN, but also TP to
FN. Strategy E performed better in this regard, as we only see a
minor increase in the number of E in FP.
During the optimization, both median validation and training
MCC as well as external test set MCC of 91 models are
increasing (Figure 3A, left). Their maxima approximately
coincide, underpinning the usefulness of the validation MCC-
based optimization procedure. While this median MCC of
all models (including 1–91 classifiers) describes the general
tendency of model improvement, it is also valuable to have a
closer look on the improvement of the individual 91 models.
During the optimization, both training and test MCC increase
for most models, when 1 to about 80 classifiers are included
(Figure 3B). However, models deteriorate at roughly > 80
included classifiers. This said, the most important area is
where the MCC is maximal (30–40 for the test set). Here, the
optimization algorithm continuously improves the models with
regard to training and test set MCC, where the last iteration
shows highest MCC values for the individual models. To select
the appropriate number of included classifiers, validation data
is useful. The validation data of the optimized model generally
follows the course of the external test data (Figure 3A, right).
Their maxima do not coincide. However, choice of the best
model with regard to validation MCC also produces a reasonable
model for the prediction of test data with a test MCC of 0.65
at 48 included scales. Interestingly, the optimum number of
included classifiers with regard to test MCC is 34 with an MCC
of 0.70 (Table 2), similar to an optimum of 29–30 included
classifiers as described in our previous study with the basic sEVC
(Vormittag et al., 2020).
Synthesis and Optimization of Amino
Acid Scale Tables
Another option to optimize the model relates to the amino
acid scale tables. The target for such optimizations was seen in
the feature values and amino acid composition in the FP and
FN groups. Adaptation of the scale tables was performed, in
a way that amino acids predominant in the respective groups
were altered in their scale table values to push observations
that have been predicted falsely over the classification boundary,
i.e., decision tree cut point. This is illustrated by the following
example. Let us assume that FP has a lower mean feature value
than FN, and, for example, that valine has a higher frequency in
FP than FN. Observations in FP are classified positive but their
data label is negative or insoluble. If we wanted observations of
FP to be classified rather insoluble, their feature value would have
to be increased for false observations to cross the classification
boundary. This said, the classification boundary is not static, but
changes with alterations in the amino acid scale table. Therefore,
small increments are made and scale improvement is monitored.
Note that the aim is to increase FP hydrophobicity, but decrease
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TABLE 1 | Modification vector and summarized model Monte Carlo cross-validation (MC-CV) performance data for the insertion strategy optimization.
Best modification vector for insertion strategy-based optimization only
Strategy A B C D E F G H
m 0.01 0 −0.01 0 0.59 −0.1 0 −0.5
Insertion strategy-based optimization only
Strategy A B C D E F H I Overall median
Astart 0.87 0.78 0.83 0.87 0.78 0.83 0.92 0.58 0.81
Aopt 0.88 0.78 0.83 0.87 0.90 0.83 0.92 0.70 0.84
Achange 1% 0% 0% 0% 12% 0% 0% 12% 4%
MCCstart 0.75 0.56 0.66 0.74 0.64 0.67 0.83 0.39 0.63
MCCopt 0.76 0.56 0.65 0.74 0.79 0.66 0.83 0.37 0.69
MCCchange 1% 0% 0% 0% 8% 0% 0% –1% 3%
Insertion strategy-based optimization combined with scale generation and optimization








The final modification vector (m) with elements for each strategy is shown, affecting the continuous prediction values after aggregation of all votes (Figure 1A). Accuracy
(A) and Matthew’s Correlation Coefficient (MCC) before (start) and after optimization (opt) are shown for each strategy. The percent change values in accuracy and MCC
are calculated by the absolute change in accuracy and MCC, respectively, divided by the range of the statistical value (1 for accuracy, 2 for MCC). Overall median is based
on the median performance data of the 1000-fold MC-CV. The MC-CV results in 91 values, which are the median of the 1000 MC-CV runs for each number of included
classifiers individually. These values are illustrated for the optimized model in Figure 3A, right. The overall median describes the median of these 91 values, which is the
optimization target function. Overall median MCC and accuracy are also shown for strategy-based optimization of scales optimized and synthesized with the scale table
optimization algorithm. *Change of MCC and accuracy of optimized/generated scales are calculated relative to the performance of literature scales without optimization
(Astart and MCCstart).
FIGURE 2 | Relative frequency of classification groups based on insertion strategies (A–H) in the first iteration (left) and the best optimization iteration (right) during
insertion strategy-based optimization with the 91 literature scales. The mean of the relative frequencies within a classification group is shown for the first iteration
(Meanstart) and for the best optimization (Meanopt), indicating that through optimization, the FP group decreases in mean relative frequency while the TN group
increases in mean relative frequency. Strategies E and H are marked additionally to guide the eye. TP: true positive; TN: true negative; FP: false positive; and FN:
false negative.
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FIGURE 3 | Matthew’s correlation coefficient (MCC) during insertion strategy-based model optimization. Scales used were the unmodified 91 literature scales.
Median MCC are shown for training, validation, and test data over optimization iterations (A, left). Validation and test MCC are shown over number of included
classifiers in the soft ensemble vote classifier (sEVC; A, right) for the best model in the optimization procedure. The median absolute deviation (MAD) of the validation
MCC above and below the median validation MCC is visualized with a shaded area. Training and test MCC over number of included classifiers are shown for the
optimization iterations until the best iteration, where median validation MCC was highest (B). Optimization iterations are illustrated by a colormap, where dark blue
represents the first iteration and dark red the best iteration, highlighted by the black dots.
FN hydrophobicity. Considering that valine is more frequently
observed in the FP group, increasing valine’s hydrophobicity
value in the scale would be beneficial, as it would increase the
average FP hydrophobicity value more than the average FN
hydrophobicity value. If this is executed for all amino acids, the
FP feature value would ideally be increased and the FN feature
value decreased, increasing overall correlation.
This optimization procedure has been performed on the entire
training dataset (384 observations) and equally sized subsets,
where the number of subsets, and therefore synthesized scales,
was 1–16, resulting in subsets with 384 to 24 training examples.
Each of the optimization procedures was performed 20 times,
resulting in 320 scale tables S[number of scales],[number of repetition].
For evaluation of the synthesized scales, the MCC of the
external test set prediction at optimal number of classifiers
as determined by validation (maximum validation MCC) is
compared (Figure 4). This validation-based model selection is a
useful strategy to select the optimal number of included classifiers
and thus the model. Additionally, the maximum MCC of the
external test set prediction is evaluated. Both metrics increase
to a maximum from one to five generated scales, where the
median of maximum test MCC is 0.71 and the median of test
MCC at maximum validation MCC is 0.70. From this maximum
toward a higher number of training subsets and likewise number
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FIGURE 4 | Test set Matthew’s correlation coefficient (MCC) of synthesized
scales. For each number of training subsets/synthesized scales, 20 repetitions
of scale generation were performed. Median and median absolute deviation
(MAD) of best test set MCC and test set MCC of best model by validation
MCC are shown.
of synthesized scales, there is a tendency of decreased model
performance. Also, best test MCC and test MCC at best validation
diverge more, probably since training subsets become smaller and
the probability of more unrepresentative scales being synthesized
rises, thus potentially decreasing the power of validation for
model selection. From this data and with the present dataset, it
would be recommended to synthesize scales from five subsets,
although most other scales also perform reasonably well.
The overall best scale table with regard to best test MCC at
maximum validation MCC is S1,5 with test MCCvali,max = 0.77
(Table 3), which is significantly better than with literature scale
tables with test MCCvali,max = 0.63. With respect to the 20
repetitions of scale synthesis, median test MCC at maximum
validation MCC for one scale is worse than for five scales
(Figure 4). The best scale table with five scales, S5,17, shows
MCCvali,max = 0.75. For the best model by validation MCC, these
scale tables show a test set accuracy of 0.86 and 0.88, respectively,
corresponding to 155 and 158 correctly classified constructs in
the test set of 184 observations.
The generation of subsets for scale synthesis was additionally
investigated with subsets containing one insertion strategy each,
amounting to eight different subsets. The median of maximum
test set MCC and test MCC at maximum validation MCC were
0.67 ± 0.03 and 0.65 ± 0.03, respectively (data not shown). They
were comparable to randomized training subset generation with
eight subsets, showing a maximum test set MCC and a test MCC
at maximum validation MCC of 0.66 ± 0.04 and 0.65 ± 0.04,
respectively, (Figure 4). Therefore, strategy-based generation of
subsets for scale synthesis was not advantageous to random
subset generation.
Optimization of the 91 literature scales with the same
algorithm that synthesized scales as described above resulted in
an improvement of training, validation and test set MCC over the
whole model space (Figure 5). A greater rate during optimization
was chosen (5%), as the lower rate employed for scale synthesis
resulted in early optimization termination with no significant
improvements in model performance (data not shown).
Combination of the Optimization
Procedures
As both above-described optimization procedures tackle
different challenges, it seems promising to combine these by
FIGURE 5 | Training, validation and test sets Matthew’s correlation coefficient (MCC) of optimized (left) and original (right) 91 literature hydrophobicity scales. The
shaded area represents the median absolute deviation (MAD) during 1000-fold Monte Carlo cross-validation.
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FIGURE 6 | Matthew’s correlation coefficient (MCC) during insertion strategy-based model optimization. Scales used were the optimized 91 literature scales (see
also Figure 4). Median MCC are shown for training, validation, and test data over optimization iterations (A, left). Validation and test MCC are shown over number of
included classifiers in the soft ensemble vote classifier (sEVC; A, right) for the best model in the optimization procedure. The median absolute deviation (MAD) of the
validation MCC above and below the median validation MCC is visualized by a shaded area. Training and test MCC over number of included classifiers are shown for
the optimization iterations until the best iteration, where median validation MCC was highest (B). Optimization iterations are illustrated by a colormap, where dark
blue represents the first iteration and dark red the best iteration, highlighted by the black dots.
TABLE 2 | Performance data of selected models on the external test set.
91 LS 91 LS,SO 91 LSopt, SO S1,5 S5,17 S8,1 S8,1,SO
MCCmax 0.63 0.70 0.72 0.77 0.77 0.72 0.76
MCCvali,max 0.63 0.65 0.71 0.77 0.75 0.72 0.71
Avali,max* 0.81 0.83 0.85 0.86 0.88 0.86 0.85
*Accuracy is shown for the model with best validation MCC. Best models’ performance data are written in bold. LS, Literature scales; SO, Strategy optimization; LSopt,
Scales optimized with scale table optimization workflow; Sx,y , Generated scale table with x scales, optimization procedure y of 20. Best test set Matthew’s Correlation
Coefficient (MCC) and test MCC of model with best validation MCC in 1000-fold MC-CV are shown.
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FIGURE 7 | Matthew’s correlation coefficient (MCC) during insertion strategy-based model optimization. Scales used were eight generated scales from scale table
set S8,1. Median MCC are shown for training, validation, and test data over optimization iterations (A, left). Validation and test MCC are shown over number of
included classifiers in the soft ensemble vote classifier (sEVC; A, right) for the best model in the optimization procedure. The median absolute deviation (MAD) of the
validation MCC above and below the median validation MCC is visualized by a shaded area. Training and test MCC over number of included classifiers are shown for
the optimization iterations until the best iteration, where median validation MCC was highest (B). Optimization iterations are illustrated by a colormap, where dark
blue represents the first iteration and dark red the best iteration, highlighted by the black dots.
adding an insertion strategy-based optimization procedure after
synthesizing or optimizing hydrophobicity scales. Strategy-based
optimization of optimized literature scale tables results in
similar trends but increased model performance compared
to models with unmodified literature scale tables (compare
Figures 3, 6). With optimized scale tables, the resulting MCC
values are higher for the training, validation and test sets
(Figure 6A). The maximum test set MCC and the test set MCC
at maximum validation MCC are increased to 0.72 and 0.71,
respectively, as compared to 0.70 and 0.65 before scale table
optimization (test set performance data summarized in Table 2).
Additionally, the performance of the model at very low and
high numbers of included classifiers is benefitted, never falling
below an MCC of 0.6 for the test set (Figure 6B). The number of
insertion strategies in the false classification groups show similar
trends as without scale table optimization, underlining that
the insertion strategy-based optimization procedure is effective
(Supplementary Figure S1).
As another example, the first set of scales generated from
eight training subsets (S8,1) was tested with the strategy-based
optimization algorithm. Figures 7A,B show that synthesized
scales still can benefit from this optimization procedure resulting
in higher MCC values for training, validation and test sets
for most models. Compared to the 91 literature scales, these
models perform 5% better with regard to validation accuracy
and MCC (Table 1). Model test set MCC is increased for
all models except for the sEVC including seven scales, which
remains at a comparable test set MCC as before strategy-based
optimization (Figure 7B), resulting in slightly decreased test
MCC and accuracy at best validation MCC (Table 2). This
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TABLE 3 | Best five scale tables, measured by highest test set Matthew’s Correlation Coefficient (MCC) at maximum validation MCC.
1 Scale 3 Scales 5 Scales
S1,5 S1,20 S3,3 S3,16 S5,17
MCCvali,max/
Amino acid
0.77 0.76 0.76 0.76 0.75
A −0.320 0.092 1.087 −0.088 −0.281 1.371 −0.161 −0.056 0.847 −0.143 0.493 0.784 0.418
R 0.168 0.312 0.454 0.867 0.201 −0.122 −0.460 0.194 −1.902 −0.845 −1.492 0.044 −0.306
N −0.668 −0.017 0.046 1.390 0.217 −0.403 −0.519 −1.132 0.050 0.377 −1.687 1.458 −1.545
D −0.751 −1.758 −0.771 −2.164 −0.555 −0.817 −0.375 −1.697 0.159 0.165 −0.368 −0.836 0.724
C 0.182 1.395 0.801 −0.660 2.344 2.143 −1.505 −1.437 −0.719 0.893 0.549 0.205 0.302
Q 0.410 0.256 −0.263 0.240 0.009 −0.898 0.285 0.181 0.015 0.386 0.913 0.047 −0.444
E −0.345 −0.656 −0.283 −0.942 −0.318 −0.396 −0.198 −0.298 −0.439 −0.444 −0.984 −0.744 −0.262
G 0.422 0.284 −0.289 −0.563 −0.190 −1.103 −1.659 −1.955 −0.073 1.105 1.775 2.545 0.446
H −0.552 −0.659 −2.698 0.134 −0.891 −2.272 0.337 0.884 1.179 −1.168 −1.083 −0.052 −1.557
I −0.321 0.795 0.271 0.059 −0.316 0.446 −0.310 −0.338 0.982 0.223 0.128 −1.003 −0.436
L 0.090 −0.118 −0.008 0.298 −0.478 −0.010 −0.276 0.371 −0.789 −1.022 0.432 −0.893 −0.393
K 0.383 0.269 −0.286 −0.014 0.018 −0.266 0.216 0.034 −1.569 1.379 −0.576 −0.050 0.505
M −0.730 −0.445 −0.601 −0.904 −2.212 −0.072 −1.271 −0.301 1.773 −2.126 −0.550 −1.816 1.239
F 3.038 −0.027 0.944 0.552 −0.294 1.117 0.822 1.835 −0.206 −0.410 0.055 −0.426 2.380
P 0.747 1.745 −0.576 1.395 0.980 0.227 0.395 1.206 0.751 0.865 −0.661 0.760 1.058
S 0.645 0.077 −1.055 0.426 0.385 −0.687 0.475 0.367 −0.062 −0.027 1.154 −0.702 −0.276
T −1.853 −2.579 −0.003 −1.159 −0.334 −0.107 1.314 1.178 1.089 −1.397 0.735 −0.759 −0.249
W 0.604 1.002 2.331 1.474 2.216 1.450 2.898 0.673 0.224 1.988 0.980 0.854 −0.010
Y −1.469 −0.766 0.743 −1.394 −0.766 −0.022 −0.204 −0.498 −1.803 0.030 −1.130 −0.281 −1.918
V 0.320 0.797 0.157 1.054 0.267 0.421 0.195 0.788 0.491 0.171 1.317 0.863 0.326
Scale tables are centered and scaled to unit variance.
shows that an improvement in median performance of models
does not necessarily result in an improved prediction outcome.
Additionally, well-performing scale tables such as S1,5 and
S5,17 were tested with the strategy-optimization workflow.
However, strategy-based optimization failed to improve model
performance using these scales, suggesting that with these scales,
systematic misclassification based on insertion strategies is not
an issue. This in turn shows, that this systematic misclassification
can be reduced by the use of other scale tables, and not
only by the strategy-based optimization. This contradicts the
assumption that insertion strategy-based misclassification is a
3-D-specific effect that cannot be captured by an amino acid
sequence-based approach (Vormittag et al., 2020). The strategy-
based optimization could theoretically be performed for all
20 × 16 generated scale sets, but would go beyond the scope
of this research.
Correlation of Scales Within Scale Tables
As pointed out earlier, the explained variance of the first principal
component (PC) from a principal component analysis (PCA) on
the 91 literature scales revealed that already 69% of the variance
is explained with one single PC (Vormittag et al., 2020). This
indicates that a significant degree of correlation between the
91 literature scales is present. After the optimization procedure,
this explained variance remained at a comparable level of 66%
(data not shown). The explained variance of the synthesized scale
tables’ first PC after PCA varied from 100 to 20% (Figure 8). An
explained variance of 100% is predefined for the situation where
only one scale was generated from the training set, as the first PC
equals this scale. From 2 to 16 scales, the explained variance is
below the above- mentioned value for the literature scales. It can
therefore be deduced that the correlation between synthesized
scales is reduced as compared to literature scales. This can be
interpreted as increased orthogonality, which was expected to
increase model performance of the sEVC. Decreased correlation
between scales could explain the improved performance of
synthesized amino acid scales in the ensemble of classifiers,
as described above. PCA of the group of scales synthesized
from dataset division by the eight insertion strategies reveals
that with 28.3 ± 3.3% of explained variance, this approach is
comparable to random division into eight insertion strategies
with 31.6 ± 3.0% (data not shown). This suggests that the
correlation between generated scales can probably not be reduced
by splitting the dataset by the insertion strategies. As discussed
above, model performance did not improve with this subset
generation strategy either.
Amino Acids With Characteristic
Hydrophobicities
The three best literature scales by feature selection in 1000-fold
MC-CV show very similar hydrophobicity values (Figure 9). This
is partly the case because they are either related to each other
or because they were generated from similar original scales (von
Heijne and Blomberg, 1979; Eisenberg et al., 1982; Zviling et al.,
2005). All synthesized scales taken together show a rather broad
distribution around zero, with few more prominent exceptions,
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FIGURE 8 | Explained variance by first principal component of synthesized
hydrophobicity scale tables. For each number of synthesized scales,
corresponding to the number of training subsets that were generated for scale
synthesis, the median of 20 repetitions is shown. The shaded area represents
the median absolute deviation (MAD).
FIGURE 9 | Median and median absolute deviation (MAD) of amino acid
hydrophobicity for all synthesized, the three best synthesized, and the three
best literature scales. The hydrophobicity scales are centered and scaled to
unit variance. For comparison purposes, the sign of hydrophobicity scales
was changed so that tryptophan (W) hydrophobicity was always positive.
Amino acids are represented with one-letter code. The MAD is visualized by a
shaded area.
such as valine (V), or tryptophan (W). Interestingly, the three
best synthesized scales also seem to agree quite well on most
of the amino acids’ hydrophobicities, which are, however, for
many examples different from the best literature scales (Best 25
individual scales shown in Supplementary Table S2). The largest
difference can be seen in the arginine (R) hydrophobicity
values. The literature scales’ low arginine value, indicating lowest
hydrophobicity, make them exceptional with respect to worse-
performing literature scales, suggesting an important role of
arginine for VLP assembly and solubility (Vormittag et al., 2020).
This is not confirmed with the synthesized amino acid scales.
This being said, it is also not contradicted. To be able to interpret
what the synthesized amino acid scale tables mean, one has to
consider the mechanism behind the optimization algorithm. In
the algorithm, the scales are analyzed for misclassification, and
the resulting feature values of misclassified observations. On
the basis of the amino acid frequency distribution within the
classification groups, the hydrophobicity scale is optimized, thus
fitting the scale to the training data of 384 observations through
the MC-CV-based procedure. Therefore, the synthesized scales
can be regarded as hydrophobicity scales that describe the cVLP
solubility problem well. Their application to other molecules or
biophysical data would yet have to be probed. (A small case
study regarding other biophysical data is shown below.) The
discrepancy between the hydrophobicity values, for example for
arginine, is probably due to the dominance of other amino acids
with respect to their influence during the optimization procedure.
This underpins the usefulness of approaching the solubility
problem both from a physicochemical and statistical perspective.
Tryptophan plays a very important role being one of the most
hydrophobic amino acids in the synthesized scales, while its
hydrophobicity is less pronounced for literature scales. Its high
hydrophobicity value contributes to insoluble classification. In
accordance with this finding, amino acids with large side chains,
such as tryptophan, have been described to be problematic for
HBcAg cVLP assembly (Karpenko et al., 2000).
Methionine (M) and histidine (H) show low hydrophobicity
values in the best three synthesized scales, but have a median
hydrophobicity close to zero considering all scales. A one-level
decision tree based on histidine content was constructed on the
entire dataset and showed a low MCC of 0.17 (data not shown),
indicating that its low hydrophobicity might be an artifact of the
random scale initiation along with its irrelevance to classify the
observations. A decision tree on methionine resulted in an MCC
of 0.41. However, observations with large methionine content
would be rather classified insoluble with this decision tree. This
speaks for a high hydrophobicity, as opposed to what can be seen
for the three best synthesized scales.
In summary, model performance was significantly enhanced
by the synthesis of scales. The above- described cases yet
underline the potential to further optimize the procedure for scale
synthesis. However, when scales are increasingly optimized, it is
important to bear in mind the danger of overfitting.
Redesigning the Soft Ensemble Vote
Classifier for Estimation of Ammonium
Sulfate Concentrations for VLP
Precipitation
Apart from cVLP solubility, there is a variety of other biophysical
properties that are interesting with regard to cVLP processing. In
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a previous study, we investigated precipitation and redissolution
of a cVLP candidate (Hillebrandt et al., 2020). In this work,
ammonium sulfate concentration to precipitate the cVLP is
determined in a screening experiment before running the
process. The screening method to determine optimal ammonium
sulfate concentrations for precipitation of the cVLPs was applied
to ten cVLPs, all constructed with insertion strategy H, contained
in the present dataset. As an example model, synthesized scales
from eight training subsets were fitted to solubility data of all
observations with insertion strategy H. Synthesized scales were
used instead of literature scales, as these were generated based on
the model space of interest. Eight models were created including
1–8 of the scales sorted by feature importance. Instead of
discretizing the prediction of the models, their continuous value
was retrieved. Thus, the individual classifiers become regression
models. However, we will still call them “classifiers” in this section
for consistency. In principle, this continuous prediction value
should be positive for all constructs as they had to be soluble
to be investigated experimentally for precipitation behavior. The
rationale behind using the continuous value is that constructs
for which the classifier is uncertain have biophysical properties
that are actually close to insolubility and therefore probably
easier to precipitate.
The ammonium sulfate concentration required to precipitate
the investigated ten constructs was mostly between 0.5 and 0.7 M,
except one concentration with 0.1 M and another concentration
with 1 M ammonium sulfate (SDS PAGE scans not shown).
Linear regression with an sEVC based on scales from set S8,1
including all eight synthesized scales resulted in an ordinary
R2 of 0.69. This indicates a linear correlation between the
continuous solubility prediction and the ammonium sulfate
concentration required for precipitation (Figure 10). Confidence
bounds are wider at the edge data points of 0.1 M and 1 M
ammonium sulfate. This is due to a higher data density in
the middle region. The linear fit almost crosses the y-axis
at 0 M ammonium sulfate concentration, which, as discussed
above, reflects a behavior of this model that would be expected.
The construct with lowest continuous solubility prediction
value precipitates at low ammonium sulfate concentrations of
only 0.1 M. Interestingly, it would be classified as insoluble
by the algorithm, while in fact being a soluble construct.
Its closeness to the solubility classification border is probably
the reason for the low associated precipitating ammonium
sulfate concentration.
It is important to note that the dataset of ammonium
sulfate concentrations is comparably small. This regression study
therefore serves as a proof-of-concept, demanding a larger
dataset for confirmation of the results and for refinement
of the method. With the limited amount of data available,
it cannot be deduced which number of included classifiers
is optimal for the regression model. While for this set of
scales S8,1, it seems that increasing classifier numbers boost
regression performance (see also Supplementary Figure S3),
the use of other scales shows inverse trends, where using
the first (and according to feature selection best) classifier
results in the best R2, e.g., set S9,1 (data not shown).
This indicates that regression for the estimation of required
FIGURE 10 | Relationship between the continuous solubility prediction value
and optimal ammonium sulfate concentration for precipitation of ten
constructs. Eight scales were used, which were generated with a scale table
optimization procedure (Set S8,1). Goodness of fit is indicated by 95%
confidence bounds and R2.
ammonium sulfate concentration for precipitation of cVLPs
would benefit from a validation procedure, realizable with larger
datasets. Additionally, the relationship between the continuous
prediction value and ammonium sulfate concentration was
assumed to be linear, due to the limited data available.
However, this might also be inappropriate, which again could
be answered with a larger dataset. Not all 16 × 20 scale
tables have been tested, since it was deemed inappropriate
given the small dataset. Finding the right set of scales by
testing all 320 scale table sets for 10 experimental data points
can quickly lead to overfitting. The first scale table of the
set with eight scales has been chosen, as it represents an
average number of generated scales. From some additional
tests with other scale tables, it might be assumed that a
small number of generated scales perform worse than a
greater number (data not shown), which would have to
be confirmed with a larger dataset of ammonium sulfate
concentration data.
CONCLUSION AND OUTLOOK
In this study, we have developed and evaluated two different
optimization algorithms to improve the performance of
an sEVC for the prediction of cVLP solubility based on
amino acid sequences and hydrophobicity scale tables.
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The dataset in this study consisted of 568 chimeric HBcAg
constructs, created by insertion of 71 different foreign peptide
sequences using 8 different insertion strategies. The sEVC
algorithm was originally developed to classify based on
91 literature hydrophobicity scales but showed systematic
misclassification for some of the insertion strategies. This was
tackled by optimizing the prediction specific for these insertion
strategies, resulting in a strategy-specific increase in validation
accuracy and MCC of up to 12 and 8%, respectively. The
second optimization algorithm modified amino acid scale tables
and was also used to synthesize 320 different hydrophobicity
scale table sets showing an MCC and accuracy of up to 0.77
and 0.88, respectively, on the external test set of 184 HBcAg
constructs. The presented models are therefore better than
other protein solubility models, typically reporting accuracies
of about 0.60 to 0.80. A combination of both procedures could
elevate the prediction performance data of worse-performing
synthesized scales to similar levels. Finally, extension of the model
to regression of the required ammonium sulfate concentration
for precipitation of ten cVLPs was evaluated, and the linear
correlation showed a promising R2 of 0.69. The results of
this study encourage to further explore the model for other
biophysical parameters and molecules.
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